<DOC>
	<DOCNO>NCT00759395</DOCNO>
	<brief_summary>This study determine highly selective enkephalinergic receptor modulator effective treatment anxious major depressive disorder .</brief_summary>
	<brief_title>Study Antidepressant Efficacy Selective , High Affinity Enkephalinergic Agonist Anxious Major Depressive Disorder ( AMDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Diagnosis major depressive disorder without psychotic feature ( MDD ) A history substance alcohol abuse within past 6 month dependence within 1 year enrollment define DSMIV criterion . Women pregnant lactate History pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Anxious Major Depressive Disorder</keyword>
</DOC>